Drug: KALETRA Injury: Exposure during pregnancy Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125635033 | KALETRA | Exposure during pregnancy | ABBVIE | 0.00 | F | 42 KG | 20160818 | COUNTRY NOT SPECIFIED |
125980671 | KALETRA | Exposure during pregnancy | VIIV | 35.00 YR | F | 0 | 20160727 | RU |
125986181 | KALETRA | Exposure during pregnancy | GLAXOSMITHKLINE | 35.00 YR | F | 0 | 20160727 | RU |
126886833 | KALETRA | Exposure during pregnancy | ABBVIE | 19.00 YR | F | 0 | 20160912 | COUNTRY NOT SPECIFIED |
127084251 | KALETRA | Exposure during pregnancy | JANSSEN | 0.00 | F | 0 | 20160901 | US |
127172942 | KALETRA | Exposure during pregnancy | RANBAXY | 19.00 YR | F | 0 | 20160917 | US |
127401151 | KALETRA | Exposure during pregnancy | ABBVIE | 36.00 YR | F | 0 | 20160913 | COUNTRY NOT SPECIFIED |
127762791 | KALETRA | Exposure during pregnancy | ABBVIE | 0.00 | F | 0 | 20160923 | COUNTRY NOT SPECIFIED |
Total Records: 8 Number of Pages: 1